Terbogrel

Terbogrel

SCHEMBL7537032

CC(C)(C)N/C(=N/C#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TBXA2RTBXAS1

The experimentally established mechanism targets of Terbogrel. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TBXA2R known ✓ P21731 20/20 0.75
TBXAS1 known ✓ P24557 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Terbogrel SCHEMBL13030802 1.00 TBXA2R (0.75) TBXA2RTBXAS1
Terbogrel SCHEMBL29383187 1.00 TBXA2R (0.75) TBXA2RTBXAS1
Terbogrel SCHEMBL7537043 1.00 TBXA2R (0.75) TBXA2RTBXAS1
Terbogrel SCHEMBL7537036 1.00 TBXA2R (0.75) TBXA2RTBXAS1
SCHEMBL9002323 0.97 TBXA2R (0.74) TBXA2RTBXAS1
SCHEMBL9002730 0.97 TBXA2R (0.75) TBXA2RTBXAS1
SCHEMBL9002333 0.94 TBXA2R (0.73) TBXA2RTBXAS1
SCHEMBL9002313 0.94 TBXA2R (0.73) TBXA2RTBXAS1
SCHEMBL9002321 0.94 TBXA2R (0.73) TBXA2RTBXAS1
SCHEMBL9002464 0.94 TBXA2R (0.72) TBXA2RTBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1190714-A2 Method for the treatment of thromboembolic disorders in patients with aspirin resistance Schrör, Karsten, Prof. Dr. (DE) 2002-03-27 EP claimed
EP-1190714-A3 Method for the treatment of thromboembolic disorders in patients with aspirin resistance Schrör, Karsten, Prof. Dr. (DE) 2002-04-03 EP disclosed
EP-1190714-A2 Method for the treatment of thromboembolic disorders in patients with aspirin resistance Schrör, Karsten, Prof. Dr. (DE) 2002-03-27 EP disclosed
EP-1190714-A2 Method for the treatment of thromboembolic disorders in patients with aspirin resistance Schrör, Karsten, Prof. Dr. (DE) 2002-03-27 EP disclosed